Sabine Witt
Overview
Explore the profile of Sabine Witt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hafner F, Johansson C, Schwarzkopf L, Forster K, Kraus Y, Flemmer A, et al.
Pulm Circ
. 2023 Dec;
13(4):e12320.
PMID: 38144949
Pulmonary hypertension (PH) is the most severe complication in preterm infants with bronchopulmonary dysplasia (BPD) and associated with significant mortality. Diagnostic and treatment strategies, however, still lack standardization. By the...
2.
Mikolasch A, Lindequist U, Witt S, Hahn V
Microorganisms
. 2022 Mar;
10(3).
PMID: 35336201
The increasing demand for new and effective antibiotics requires intelligent strategies to obtain a wide range of potential candidates. Laccase-catalyzed reactions have been successfully applied to synthesize new β-lactam antibiotics...
3.
Mikolasch A, Hammer E, Witt S, Lindequist U
AMB Express
. 2020 Oct;
10(1):177.
PMID: 33006678
Trametes spec. laccase (EC 1.10.3.2.) mediates the oxidative coupling of 6-aminopenicillanic, 7-aminocephalosporanic, and 7-aminodesacetoxycephalosporanic acid with 2,5-dihydroxybenzoic acid derivatives to form new penicillin and cephalosporin structures, respectively. The heteromolecular hybrid...
4.
Griese M, Kohler M, Witt S, Sebah D, Kappler M, Wetzke M, et al.
Trials
. 2020 Apr;
21(1):307.
PMID: 32245508
Background: Interstitial lung diseases in children (chILD) are rare and consist of many different entities that affect the parenchyma of the lungs, leading to a chronic lung disease. The natural...
5.
Walscher J, Witt S, Schwarzkopf L, Kreuter M
Respir Res
. 2020 Mar;
21(1):73.
PMID: 32216792
Background: Interstitial lung disease (ILD) is a heterogeneous group of mainly chronic lung diseases differing in disease course and prognosis. For most subtypes, evidence on relevance and outcomes of hospitalisations...
6.
Witt S, Krauss E, Nieto Barbero M, Muller V, Bonniaud P, Vancheri C, et al.
Respir Res
. 2019 Mar;
20(1):47.
PMID: 30823880
Background: Idiopathic pulmonary fibrosis (IPF) is a rare disease with a median survival of 3-5 years after diagnosis with limited treatment options. The aim of this study is to assess...
7.
Schwarzkopf L, Witt S, Waelscher J, Polke M, Kreuter M
Respir Res
. 2018 Apr;
19(1):73.
PMID: 29695236
Background: Interstitial lung diseases (ILDs) are associated with a high burden of disease. However, data on the prognostic impact of comorbidities and comorbidity-related pharmaceutical treatments in patients with various ILDs...
8.
Mikolasch A, Hildebrandt O, Schluter R, Hammer E, Witt S, Lindequist U
Appl Microbiol Biotechnol
. 2016 Jan;
100(11):4885-99.
PMID: 26780358
The rapidly increasing problem of antimicrobial-drug resistance requires the development of new antimicrobial agents. The laccase-catalyzed amination of dihydroxy aromatics is a new and promising method to enlarge the range...
9.
Kreuter M, Herth F, Wacker M, Leidl R, Hellmann A, Pfeifer M, et al.
Biomed Res Int
. 2015 Dec;
2015:123876.
PMID: 26640781
Despite a number of prospective registries conducted in past years, the current epidemiology of interstitial lung diseases (ILD) is still not well defined, particularly regarding the prevalence and incidence, their...
10.
Lindequist U, Julich W, Witt S
Phytochemistry
. 2015 Mar;
114:102-8.
PMID: 25817834
In contrast to well-studied and broadly used Ganoderma species, such as Ganoderma lucidum and Ganoderma applanatum, knowledge regarding Ganoderma pfeifferi is very limited. Herein is an overview of the phytochemistry,...